Table 2.
Total | Awarenessa | Treatmentb | Controlc | |
---|---|---|---|---|
N | n (%) | n (%) | n (%) | |
Hypertension d | 2,164 | 1,809 (83.6) | 1,600 (73.9) | 893 (41.3) |
Overall trend P-valuee | <0.001 | 0.6415 | <0.001 | |
Males | ||||
40–44 years | 8 | 2 (25.0) | 1(100) | 0 (0) |
45–54 years | 97 | 62 (63.9) | 45 (95.7) | 20 (50.0) |
55–64 years | 201 | 143 (71.1) | 117 (90.7) | 50 (49.5) |
65+ years | 542 | 443 (81.7) | 386 (93.0) | 233 (74.9) |
P-value for trende | <0.001 | 0.9176 | <0.001 | |
Females | ||||
40–44 years | 7 | 3 (42.9) | 2 (66.7) | 1 (100) |
45–54 years | 186 | 152 (81.72) | 127 (96.2) | 76 (67.3) |
55–64 years | 386 | 338 (87.6) | 301 (95.3) | 152 (59.1) |
65+ years | 737 | 666 (90.4) | 621 (96.7) | 361 (70.4) |
P-value for trende | <0.001 | 0.2354 | 0.0826 |
aAwareness: Self-reported diagnosis by a health professional among those meeting the definition of hypertension.
bTreatment: Self-reported use of medication among those meeting the definition of hypertension.
cControl: Measured systolic blood pressure <140 mm Hg and diastolic blood pressure <90 mm Hg, among those meeting the definition of hypertension.
dHypertension: Systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or self-reported use of medication.
e P-value for linear trend in across age groups from baseline to follow-up, at α = 0.05.